Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence Biomed" or the "Company") today announced that it has entered into a conditional share sale agreement with Psyence Group (CSE: PSYG) (as seller) for the ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

Israel stocks were lower after the close on Thursday, as losses in the Biomed, Real Estate and Banking sectors led shares ...

Demand is inching upward, says the CEO of San Diego-based BioMed. Tim Schoen and his team at BioMed Realty have a challenge: ...

“We are excited about Petra joining our team as Brand Ambassador. Her broad and deep experience will be invaluable to us as we bring our next generation colorectal cancer screening product to market, ...

Initiated Phase IIb study of nature-derived psilocybin as a potential treatment for Adjustment Disorder in Palliative Care Expanded pipeline into Alcohol Use Disorder (AUD) and Substance Use Disorders ...

The new research team led by Dr. Stefanie Bärthel will work on developing next-generation immunotherapies by leveraging the ...

Orange Biomed announced today that it plans to showcase its microfluidic-based A1C test at the 2024 Diabetes Technology ...

Experts say squats can help avoid knee pain when done right. Here, physical therapists explain squat benefits and proper ...

Researchers have developed a potential breakthrough treatment for osteosarcoma, the most common form of bone cancer. Learn ...

Citizens JMP director of financial technology research Devin Ryan joins Market Domination to discuss his top crypto and fintech plays and the sectors' outlook as the election looms ahead. Ryan points ...

Israel equities were lower at the close on Thursday, as losses in the Biomed, Real Estate and Banking sectors propelled ...